Treatment
Medication clinical trials
We’re tracking 7,138 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06434376Enrolling by invitationEarly Phase 1
Personalized immune therapy for ctDNA-positive colorectal cancer
This trial tests a personalized immune therapy (like a custom vaccine) for people with colorectal cancer that has a positive ctDNA MRD test after surgery. It aims to use the body's own immune system to target any remaining cancer cells and prevent the cancer from coming back.
Wenzhou, ZhejiangAges 18–80 - NCT06434831Recruiting
Nerve response study during sacral neuromodulation for overactive bladder
This trial is for people with overactive bladder who are already scheduled to receive a nerve stimulator implant (sacral neuromodulation). The study will measure how your body's automatic nervous system responds when the device is turned on, which may help doctors understand how the treatment works.
LilleAges 18 years+ - NCT06426498Recruiting
Ultrasound and temporary blind spot study
This study tests whether a focused ultrasound technique can create a temporary blind spot in the vision. Researchers hope this will help them find the right ultrasound dose for each person, with the goal of treating certain brain conditions.
Charleston, South CarolinaAges 18–70 - NCT06425029Recruiting
Music app therapy for hard-to-control epilepsy with RNS
This study is testing a music-based app that you can use at home to help treat seizures. It is for adults with focal epilepsy who already have an RNS device and whose seizures are not controlled by medication.
Worcester, MassachusettsAges 18 years+ - NCT06433310RecruitingPhase 4
A dietary supplement's effect on gut fungi in healthy adults
This study tests whether a dietary supplement (L-phenylalanine) can affect the natural balance of fungi in the gut. Healthy volunteers take the supplement for a short time, and researchers check how it changes their gut fungi.
New York, New YorkAges 18 years+ - NCT06431581Recruiting
Mobile health app to improve pregnancy and birth outcomes
This trial tests whether a smartphone-based health program can improve birth outcomes for pregnant women. If you are between 13 and 27 weeks pregnant, own a smartphone, and plan to deliver at a participating hospital, you may be eligible.
Dhulikhel, BagmatiAges 18 years+ - NCT06423378Enrolling by invitationPhase 2
Kneebar implant for knee pain and bone marrow lesion
This trial tests a new type of implant (a fiber-reinforced kneebar) for people with knee pain caused by a bone marrow lesion (BML) and osteoarthritis. The goal is to see if it helps relieve pain and improve knee function.
Nashville, TennesseeAges 18–75 - NCT06429995Enrolling by invitation
Standard follow-up program for breast cancer patients
This trial tests a standard follow-up program for people with breast cancer who are getting radiotherapy. It aims to see how well the program supports patients after treatment.
GroningenAges 18–99 - NCT06424067RecruitingPhase 2
Fingolimod for advanced lung cancer
This trial tests if the drug fingolimod can help people with advanced non-small cell or small cell lung cancer that has worsened after at least two previous treatments. Fingolimod is a pill taken daily that may help the immune system fight the cancer.
Charleston, South CarolinaAges 18 years+ - NCT06427538Recruiting
Chest drain flushing for lung infections
This study tests whether regularly flushing the chest tube with a small amount of liquid helps prevent blockages in people who have a severe lung infection that spreads to the chest cavity. If you need a chest tube for this type of infection, you may be able to join.
Sterling Heights, MichiganAges 18 years+ - NCT06434571RecruitingPhase 2
Comparing two sleep treatments for people with MS
This trial tests if talking with a sleep coach by video is better than a web-based program for improving sleep, reducing fatigue, and protecting the brain in people with multiple sclerosis (MS). Both treatments focus on changing thoughts and habits around sleep.
Kansas City, KansasAges 18–65 - NCT06437574RecruitingPhase 2
Cholesterol-lowering and immune response in prostate cancer
This trial tests whether taking a daily cholesterol-lowering medication (Vytorin or ezetimibe) can boost your immune system to help fight prostate cancer. It is for men with low- or intermediate-risk prostate cancer who are on active surveillance and planning a biopsy.
Los Angeles, CaliforniaAges 18 years+ - NCT06421532Enrolling by invitationPhase 2
Testing LXB to clear protein buildup in CAA
This study tests whether the drug LXB (sodium oxybate) can help clear abnormal protein buildup in the brain's small blood vessels (CAA). Participants will take LXB nightly for 8 weeks and have MRIs and spinal taps to measure changes.
LeidenAges 30 years+ - NCT06424184Recruiting
Fast brain stimulation for addiction and depression
This study tests a quick, non-invasive brain stimulation method (rTMS) to help people who use stimulants like cocaine or methamphetamine and also feel depressed. The goal is to see if it can reduce cravings and improve mood.
Dallas, TexasAges 18–65 - NCT06436534Recruiting
Ganciclovir for stubborn allergic rhinitis
This study tests whether an antiviral medicine called ganciclovir (in capsule form) can help people with stubborn moderate-to-severe allergic rhinitis that doesn't improve with standard treatments. If you have year-round allergies to dust mites and your symptoms are still bothersome, this trial may be an option for you.
Wuhan, HubeiAges 18–65 - NCT06439524RecruitingPhase 3
Medication after endometriosis surgery study
This trial tests whether taking a medication (Rel-CT) after surgery helps improve outcomes for people with endometriosis. It may reduce the chance of symptoms returning after the tissue is removed.
Wynnewood, PennsylvaniaAges 18 years+ - NCT06435260RecruitingPhase 2
Short radiation, chemo, and immunotherapy before pancreas cancer surgery
This trial tests a short course of radiation combined with chemo and the immunotherapy drug camrelizumab before surgery for pancreatic cancer. It aims to shrink tumor to make removal easier and improve outcomes.
Shijiazhuang, HebeiAges 18–75 - NCT06422871Recruiting
Observing HeRO Graft and Super HeRO in dialysis patients
This study is tracking how well the HeRO Graft and Super HeRO work for people on dialysis. If you already have one of these devices, joining helps doctors see how it performs over time.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06436053Recruiting
Pacing to improve heart function study
This study tests a new way to pace the heart to see if it can improve how well the heart pumps. It uses a special Abbott pacemaker to pace a part of the heart called the left bundle branch and adjust the timing to match your natural heart rhythm.
San Donato Milanese, MIAges 18 years+ - NCT06425211Recruiting
Pelvic Floor Therapy for ED & Premature Ejaculation
This trial tests if pelvic floor therapy (exercises) can help men with erectile dysfunction or premature ejaculation. It may be a drug-free option to improve your sexual health.
Bogotá, CundinamarcaAges 18–100 - NCT06428409RecruitingPhase 1/Phase 2
A study of MK-2870 for several gastrointestinal cancers
This trial is testing a new drug called MK-2870, alone or with other treatments, for people with advanced colorectal, pancreatic, or bile duct cancer. It aims to see if the drug can help shrink or control the cancer.
Los Angeles, CaliforniaAges 18 years+ - NCT04801290Recruiting
TIPS procedure for people with worsening liver cirrhosis
This trial studies the TIPS procedure in people with decompensated (worsening) liver cirrhosis to see how it helps. You may be considered if you need a TIPS procedure and can receive care at the study hospital.
Hanover, Lower SaxonyAges 18–99 - NCT04759274Recruiting
Personalized water pill dosing support for kidney and fluid overload
This trial tests a decision-support tool to help your care team safely adjust water pills (“diuretics”) when you have kidney disease and fluid buildup. It may help reduce swelling by guiding dosing using your home weight and blood pressure.
Dallas, TexasAges 18 years+ - NCT06410209RecruitingPhase 2
Walking Juntos: Smartphone program to help Hispanic cancer survivors be active
This study will test if a smartphone program and social media group can help Hispanic/Latino teens and young adults who had childhood cancer become more physically active. You would wear a Fitbit and use a phone app with culturally tailored tips and support.
Mesa, ArizonaAges 15–20
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,138 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.